Sells blood tests that can diagnose, prognose, or monitor autoimmune diseases.
Industry: Health Care
First Day Return: +32.7%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 09/19/2014 |
Offer Price | $14.00 |
Price Range $14.00 - $16.00 | |
Offer Shares (mm) | 3.6 |
Deal Size ($mm) | $50 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 09/18/2019 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $50 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Vista, CA, United States |
Founded | 2002 |
Employees at IPO | 144 |
Website www.exagen.com |